AU2016359545B2 - Peptides and uses therefor as antiviral agents - Google Patents

Peptides and uses therefor as antiviral agents Download PDF

Info

Publication number
AU2016359545B2
AU2016359545B2 AU2016359545A AU2016359545A AU2016359545B2 AU 2016359545 B2 AU2016359545 B2 AU 2016359545B2 AU 2016359545 A AU2016359545 A AU 2016359545A AU 2016359545 A AU2016359545 A AU 2016359545A AU 2016359545 B2 AU2016359545 B2 AU 2016359545B2
Authority
AU
Australia
Prior art keywords
peptide
psp
sequence
amino acid
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016359545A
Other languages
English (en)
Other versions
AU2016359545A1 (en
Inventor
Mohamed Rajik MOHAMED IBRAHIM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viramatix Sdn Bhd
Original Assignee
Viramatix Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viramatix Sdn Bhd filed Critical Viramatix Sdn Bhd
Publication of AU2016359545A1 publication Critical patent/AU2016359545A1/en
Application granted granted Critical
Publication of AU2016359545B2 publication Critical patent/AU2016359545B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2016359545A 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents Ceased AU2016359545B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides
MYPI2015002751 2015-11-27
US201662335201P 2016-05-12 2016-05-12
US62/335,201 2016-05-12
US201662425913P 2016-11-23 2016-11-23
US62/425,913 2016-11-23
PCT/IB2016/057146 WO2017090010A1 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Publications (2)

Publication Number Publication Date
AU2016359545A1 AU2016359545A1 (en) 2018-07-12
AU2016359545B2 true AU2016359545B2 (en) 2021-06-10

Family

ID=58763140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016359545A Ceased AU2016359545B2 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Country Status (7)

Country Link
US (1) US10538554B2 (https=)
EP (1) EP3380493A4 (https=)
JP (2) JP2019506840A (https=)
CN (1) CN108699113A (https=)
AU (1) AU2016359545B2 (https=)
MY (2) MY184269A (https=)
WO (1) WO2017090010A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11376306B2 (en) * 2017-05-26 2022-07-05 Viramatix Sdn Bhd Peptides and uses therefor as antiviral agents
WO2021042039A1 (en) * 2019-08-29 2021-03-04 Ajk Pharmaceutical Llc Synthetic antimicrobial peptides
CN111100194B (zh) * 2020-02-21 2022-03-25 佛山科学技术学院 一种抗菌肽pd-l4在抑制禽流感病毒中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130190228A1 (en) * 2008-06-13 2013-07-25 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60221705T2 (de) * 2001-03-22 2008-06-05 The United States of America, represented by the Secretary, Dept. of Health and Human Services, the Natl. Institutes of Health, Office of Technology Transfer Glykosylierungsresistente cyanovirine und damit verbundene konjugate, zusammensetzungen, nukleinsäuren, vektoren, wirtszellen, herstellungsverfahren sowie verfahren zur verwendung nichtglykosylierter cyanovirine
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
US7148404B2 (en) * 2004-05-04 2006-12-12 Novozymes A/S Antimicrobial polypeptides
MX2007015105A (es) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Formulacion de vacuna de influenza a base de peptido.
US20070073039A1 (en) * 2005-09-29 2007-03-29 Chisari Francis V Peptides that inhibit viral infections
GB0718966D0 (en) 2007-09-28 2007-11-07 Liverpool School Of Tropical M Bacterial vaccine
MY160435A (en) * 2008-06-12 2017-03-15 Univ Putra Malaysia A novel antiviral peptide against avian influenza virus h9n2
GB201012651D0 (en) * 2010-07-28 2010-09-15 Univ Edinburgh Peptides
WO2013086499A2 (en) * 2011-12-09 2013-06-13 Ceres, Inc. Transgenic plants having altered biomass composition
EP3013425B1 (en) * 2013-06-27 2020-09-09 Rutgers, the State University of New Jersey Leukotoxin for use in the treatment of ocular disease
US11376306B2 (en) * 2017-05-26 2022-07-05 Viramatix Sdn Bhd Peptides and uses therefor as antiviral agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130190228A1 (en) * 2008-06-13 2013-07-25 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RAJIK MOHAMED ET AL, "Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2", VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, (2009-06-05), vol. 6, no. 1, page 74 *
YANWEI ZHONG ET AL, "Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A", VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, (2011-12-15), vol. 8, no. 1, doi:10.1186/1743-422X-8-542, ISSN 1743-422X, page 542 *

Also Published As

Publication number Publication date
CN108699113A (zh) 2018-10-23
MY189021A (en) 2022-01-19
MY184269A (en) 2021-03-30
EP3380493A4 (en) 2019-07-31
US10538554B2 (en) 2020-01-21
US20180346516A1 (en) 2018-12-06
JP2022088370A (ja) 2022-06-14
AU2016359545A1 (en) 2018-07-12
JP2019506840A (ja) 2019-03-14
WO2017090010A1 (en) 2017-06-01
EP3380493A1 (en) 2018-10-03

Similar Documents

Publication Publication Date Title
EP2376100B1 (en) Peptidomimetic macrocycles
Leneva et al. Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol
US6037348A (en) Inhibition of viral replication
CN101848719B (zh) 流感抑制组合物和方法
JP2022088370A (ja) 抗ウイルス剤としてのペプチドおよびこのための使用
CA2836511A1 (en) Matriptase inhibitors and uses thereof against orthomyxoviridae infections
US9221874B2 (en) Antiviral peptides against influenza virus
US11376306B2 (en) Peptides and uses therefor as antiviral agents
JP6910043B2 (ja) ヘマグルチニン結合ペプチド、および、これを含むインフルエンザウイルス感染症の予防・治療薬
RU2676699C1 (ru) Аминокислотные производные 2-норборнануксусной кислоты и их противогриппозная активность
Sorbera et al. RWJ-270201
RU2492178C1 (ru) Противовирусный пептид, подавляющий репликацию вируса гриппа
HK40025030A (en) Peptides and uses therefor as antiviral agents
EA033921B1 (ru) Производные сиаловой кислоты и их применение в лечении инфекций, вызываемых вирусом гриппа
EP0879055A1 (en) Inhibition of viral replication

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired